SuPreme Study: a Protocol to Study the Neuroprotective Potential of Sulfate Among Very/extremely Preterm Infants

Overview

Journal BMJ Open

Specialty General Medicine

Date 2023 Jul 14

PMID 37451710

Authors

Elizabeth M Hurrion

Nadia Badawi

Roslyn N Boyd

Catherine Morgan

Kristen Gibbons

Stefanie Hennig

Pieter Koorts

Manbir Chauhan

Francis Bowling

Vicki Flenady

Sailesh Kumar

Paul A Dawson

Affiliations

Soon will be listed here.

Abstract

Introduction: Antenatal maternal magnesium sulfate (MgSO) administration is a proven efficacious neuroprotective treatment reducing the risk of cerebral palsy (CP) among infants born preterm. Identification of the neuroprotective component with target plasma concentrations could lead to neonatal treatment with greater efficacy and accessibility.

Methods And Analysis: This is a prospective observational cohort study, in three tertiary Australian centres. Participants are preterm infants, irrespective of antenatal MgSO exposure, born in 2013-2020 at 24 to 31 weeks gestation, and followed up to 2 years corrected age (CA) (to September 2023). 1595 participants are required (allowing for 17% deaths/loss to follow-up) to detect a clinically significant reduction (30% relative risk reduction) in CP when sulfate concentration at 7 days of age is 1 SD above the mean.A blood sample is collected on day 7 of age for plasma sulfate and magnesium measurement. In a subset of participants multiple blood and urine samples are collected for pharmacokinetic studies, between days 1-28, and in a further subset mother/infant blood is screened for genetic variants of sulfate transporter genes.The primary outcome is CP. Surviving infants are assessed for high risk of CP at 12-14 weeks CA according to Prechtl's Method to assess General Movements. Follow-up at 2 years CA includes assessments for CP, cognitive, language and motor development, and social/behavioural difficulties.Multivariate analyses will examine the association between day 7 plasma sulfate/magnesium concentrations with adverse neurodevelopmental outcomes. A population pharmacokinetic model for sulfate in the preterm infant will be created using non-linear mixed-effects modelling.

Ethics And Dissemination: The study has been approved by Mater Misericordiae Ltd Human Research Ethics Committee (HREC/14/MHS/188). Results will be disseminated in peer-reviewed journal publications, and provided to the funding bodies. Using consumer input, a summary will be prepared for participants and consumer groups.

Citing Articles

Sulfation pathways in times of change.

Mueller J, Fietz D, Dias I Essays Biochem. 2024; 68(4):379-382.

PMID: 39630031 PMC: 11625859. DOI: 10.1042/EBC20230099.

References

Morag I, Yakubovich D, Stern O, Siman-Tov M, Schushan-Eisen I, Strauss T . Short-term morbidities and neurodevelopmental outcomes in preterm infants exposed to magnesium sulphate treatment. J Paediatr Child Health. 2016; 52(4):397-401. DOI: 10.1111/jpc.13103. View

Dawson P . Sulfate in fetal development. Semin Cell Dev Biol. 2011; 22(6):653-9. DOI: 10.1016/j.semcdb.2011.03.004. View

Ostrander B, Bardsley T, Korgenski E, Greene T, Bonkowsky J . Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants. Pediatr Neurol. 2016; 59:41-6. PMC: 4912928. DOI: 10.1016/j.pediatrneurol.2016.02.012. View

Yamaguchi Y . Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. Semin Cell Dev Biol. 2001; 12(2):99-106. DOI: 10.1006/scdb.2000.0238. View

Bowling F, Heussler H, McWhinney A, Dawson P . Plasma and urinary sulfate determination in a cohort with autism. Biochem Genet. 2012; 51(1-2):147-53. DOI: 10.1007/s10528-012-9550-0. View

Badawi N, Honan I, Finch-Edmondson M, Hogan A, FitzGerald J, Imms C . The Australian & New Zealand Cerebral Palsy Strategy. Dev Med Child Neurol. 2020; 62(8):885. DOI: 10.1111/dmcn.14554. View

Schwartz N, Domowicz M . Proteoglycans in brain development and pathogenesis. FEBS Lett. 2018; 592(23):3791-3805. DOI: 10.1002/1873-3468.13026. View

Rigo J, Pieltain C, Christmann V, Bonsante F, Moltu S, Iacobelli S . Serum Magnesium Levels in Preterm Infants Are Higher Than Adult Levels: A Systematic Literature Review and Meta-Analysis. Nutrients. 2017; 9(10). PMC: 5691741. DOI: 10.3390/nu9101125. View

Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K . Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell. 1996; 86(2):209-19. DOI: 10.1016/s0092-8674(00)80093-8. View

10.

Croft S, Stride C, Maughan B, Rowe R . Validity of the strengths and difficulties questionnaire in preschool-aged children. Pediatrics. 2015; 135(5):e1210-9. DOI: 10.1542/peds.2014-2920. View

11.

Lamsal R, Dutton D, Zwicker J . Using the ages and stages questionnaire in the general population as a measure for identifying children not at risk of a neurodevelopmental disorder. BMC Pediatr. 2018; 18(1):122. PMC: 5883588. DOI: 10.1186/s12887-018-1105-z. View

12.

Llanos-Paez C, Staatz C, Lawson R, Hennig S . A Population Pharmacokinetic Model of Gentamicin in Pediatric Oncology Patients To Facilitate Personalized Dosing. Antimicrob Agents Chemother. 2017; 61(8). PMC: 5527572. DOI: 10.1128/AAC.00205-17. View

13.

Einspieler C, PRECHTL H, Ferrari F, Cioni G, Bos A . The qualitative assessment of general movements in preterm, term and young infants--review of the methodology. Early Hum Dev. 1998; 50(1):47-60. DOI: 10.1016/s0378-3782(97)00092-3. View

14.

Simmons D, Rakoczy J, Jefferis J, Lourie R, McIntyre H, Dawson P . Human placental sulfate transporter mRNA profiling from term pregnancies identifies abundant SLC13A4 in syncytiotrophoblasts and SLC26A2 in cytotrophoblasts. Placenta. 2013; 34(4):381-4. DOI: 10.1016/j.placenta.2013.01.017. View

15.

Rakoczy J, Lee S, Weerasekera S, Simmons D, Dawson P . Placental and fetal cysteine dioxygenase gene expression in mouse gestation. Placenta. 2015; 36(8):956-9. DOI: 10.1016/j.placenta.2015.06.003. View

16.

Zhang Z, Dawson P, Piper M, Simmons D . Postnatal N-acetylcysteine administration rescues impaired social behaviors and neurogenesis in Slc13a4 haploinsufficient mice. EBioMedicine. 2019; 43:435-446. PMC: 6557756. DOI: 10.1016/j.ebiom.2019.03.081. View

17.

van Esdonk M, Tai B, Cotterill A, Charles B, Hennig S . Prediction of glycaemic control in young children and adolescents with type 1 diabetes mellitus using mixed-effects logistic regression modelling. PLoS One. 2017; 12(8):e0182181. PMC: 5540397. DOI: 10.1371/journal.pone.0182181. View

18.

Hodek J, von der Schulenburg J, Mittendorf T . Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers. Health Econ Rev. 2012; 1(1):6. PMC: 3395039. DOI: 10.1186/2191-1991-1-6. View

19.

. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol. 2000; 42(12):816-24. DOI: 10.1017/s0012162200001511. View

20.

Cole D, Oulton M, Stirk L, Magor B . Increased inorganic sulfate concentrations in amniotic fluid. J Perinat Med. 1992; 20(6):443-7. DOI: 10.1515/jpme.1992.20.6.443. View